Literature DB >> 28528669

Modulation of Ion Channels by Cysteine-Rich Peptides: From Sequence to Structure.

Mehdi Mobli1, Eivind A B Undheim2, Lachlan D Rash3.   

Abstract

Venom peptides are natural ligands of ion channels and have been used extensively in pharmacological characterization of various ion channels and receptors. In this chapter, we survey all known venom peptide ion-channel modulators. Our survey reveals that the majority of venom peptides characterized to date target voltage-gated sodium or potassium channels. We further find that the majority of these peptides are found in scorpion and spider venoms. We discuss the influence of the pharmacological tools available in biasing discovery and the classical "toxin-to-sequence" approach to venom peptide biodiscovery. The impact of high-throughput sequencing on the existing discovery framework is likely to be significant and we propose here an alternative "sequence-to-toxin" approach to peptide screening, relying more on recently developed high-throughput methods. Methods for production and characterization of disulfide rich toxins in a high-throughput setting are then described, focusing on bacterial protein expression and solution state structural characterization by NMR spectroscopy. Finally, the role of X-ray crystallography and cryo-EM are highlighted by discussing the currently known channel-peptide complexes.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Channel modulators; Cysteine-rich peptides; Disulfide-rich peptides; Gating modifier; Ion channels; Peptide structure; Pore blockers; Protein structure; Protein–protein interactions; Venom peptides

Mesh:

Substances:

Year:  2017        PMID: 28528669     DOI: 10.1016/bs.apha.2017.03.001

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  7 in total

1.  Mapping the Molecular Surface of the Analgesic NaV1.7-Selective Peptide Pn3a Reveals Residues Essential for Membrane and Channel Interactions.

Authors:  Alexander Mueller; Zoltan Dekan; Quentin Kaas; Akello J Agwa; Hana Starobova; Paul F Alewood; Christina I Schroeder; Mehdi Mobli; Jennifer R Deuis; Irina Vetter
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-19

2.  Cloning, expression and identification of KTX-Sp4, a selective Kv1.3 peptidic blocker from Scorpiops pococki.

Authors:  Yan Zou; Feng Zhang; Yaxian Li; Yuanfang Wang; Yi Li; Zhengtao Long; Shujuan Shi; Li Shuai; Jiukai Liu; Zhiyong Di; Shijin Yin
Journal:  Cell Biosci       Date:  2017-11-06       Impact factor: 7.133

3.  Secreted Cysteine-Rich Repeat Proteins "SCREPs": A Novel Multi-Domain Architecture.

Authors:  Michael Maxwell; Eivind A B Undheim; Mehdi Mobli
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

4.  Can we resolve the taxonomic bias in spider venom research?

Authors:  Volker Herzig; Glenn F King; Eivind A B Undheim
Journal:  Toxicon X       Date:  2019-01-02

5.  N-Terminal Tagging with GFP Enhances Selectivity of Agitoxin 2 to Kv1.3-Channel Binding Site.

Authors:  Oksana V Nekrasova; Alexandra L Primak; Anastasia A Ignatova; Valery N Novoseletsky; Olga V Geras'kina; Ksenia S Kudryashova; Sergey A Yakimov; Mikhail P Kirpichnikov; Alexander S Arseniev; Alexey V Feofanov
Journal:  Toxins (Basel)       Date:  2020-12-16       Impact factor: 4.546

6.  Assigning biological function using hidden signatures in cystine-stabilized peptide sequences.

Authors:  S M Ashiqul Islam; Christopher Michel Kearney; Erich J Baker
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

7.  Stability and Safety of Inhibitor Cystine Knot Peptide, GTx1-15, from the Tarantula Spider Grammostola rosea.

Authors:  Tadashi Kimura
Journal:  Toxins (Basel)       Date:  2021-09-03       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.